> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Oncologic Panel to Review Avastin, Herceptin Proposed Biosimilars
- URL: https://www.fdaweb.com/oncologic-panel-to-review-avastin-herceptin-proposed-biosimilars/
- Published: 2017-06-07T12:00:00.000Z
- Updated: 2026-09-14T22:27:47.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5138880

*Federal Register* notice: FDA has announced a 7/13 Oncologic Drugs Advisory Committee meeting. During the morning session, the panel will discuss an Amgen BLA for a proposed biosimilar to Genentech/Roche’s colorectal cancer therapy Avastin (bevacizumab). In the afternoon session, the committee will discuss a Mylan BLA for a proposed biosimilar to Genentech Inc.’s breast cancer therapy Herceptin (trastuzumab). To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-06-07/pdf/2017-11819.pdf?ref=fdaweb.com).